Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice

  1. Ying Ann Chiao  Is a corresponding author
  2. Huiliang Zhang
  3. Mariya Sweetwyne
  4. Jeremy Whitson
  5. Ying Sonia Ting
  6. Nathan Basisty
  7. Lindsay K Pino
  8. Ellen Quarles
  9. Ngoc-Han Nguyen
  10. Matthew D Campbell
  11. Tong Zhang
  12. Matthew J Gaffrey
  13. Gennifer Merrihew
  14. Lu Wang
  15. Yongping Yue
  16. Dongsheng Duan
  17. Henk L Granzier
  18. Hazel H Szeto
  19. Wei-Jun Qian
  20. David Marcinek
  21. Michael J MacCoss
  22. Peter Rabinovitch  Is a corresponding author
  1. Oklahoma Medical Research Foundation, United States
  2. University of Washington, United States
  3. Buck Institute for Research on Aging, United States
  4. Pacific Northwest National Laboratory, United States
  5. University of Missouri, United States
  6. University of Arizona, United States
  7. Social Profit Network, United States

Abstract

Diastolic dysfunction is a prominent feature of cardiac aging in both mice and humans. We show here that 8-week treatment of old mice with the mitochondrial targeted peptide SS-31 (elamipretide) can substantially reverse this deficit. SS-31 normalized the increase in proton leak and reduced mitochondrial ROS in cardiomyocytes from old mice, accompanied by reduced protein oxidation and a shift towards a more reduced protein thiol redox state in old hearts. Improved diastolic function was concordant with increased phosphorylation of cMyBP-C Ser282 but was independent of titin isoform shift. Late-life viral expression of mitochondrial-targeted catalase (mCAT) produced similar functional benefits in old mice and SS-31 did not improve cardiac function of old mCAT mice, implicating normalizing mitochondrial oxidative stress as an overlapping mechanism. These results demonstrate that pre-existing cardiac aging phenotypes can be reversed by targeting mitochondrial dysfunction and implicate mitochondrial energetics and redox signaling as therapeutic targets for cardiac aging.

Data availability

Data file for metabolomic analysis (Table S1) and statistics of all proteins identified by proteomic analysis (Table S3) have been provided as supplementary materials.The raw mass spec files for proteomics analysis of S-glutathionylation were uploaded to MassIVE and can be accessed via the following link ftp://massive.ucsd.edu/MSV000085329/The raw mass spectrometry files for global proteomic analysis were uploaded to MassIVE and can be accessed via the following link ftp://massive.ucsd.edu/MSV000084961/The image files for ROS (Fig 2a and b) and senescence (Fig 4b and c) analyses can be accessed via the following link and were also included as supporting zip documents. https://www.dropbox.com/sh/0r50ew6xnpunc3t/AAA_HbJ0fQwhOUpDbI9Oq07va?dl=0

Article and author information

Author details

  1. Ying Ann Chiao

    Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, OKlahom City, United States
    For correspondence
    Ann-Chiao@omrf.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1256-4335
  2. Huiliang Zhang

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Mariya Sweetwyne

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jeremy Whitson

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ying Sonia Ting

    Genome Science, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Nathan Basisty

    Buck Institute for Research on Aging, Novato, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Lindsay K Pino

    Genome Science, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Ellen Quarles

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Ngoc-Han Nguyen

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Matthew D Campbell

    Radiology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Tong Zhang

    Biological Sciences Division, Pacific Northwest National Laboratory, Richland, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Matthew J Gaffrey

    Biological Sciences Division, Pacific Northwest National Laboratory, Richland, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Gennifer Merrihew

    Genome Science, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Lu Wang

    Environmental and Occupational Health Sciences, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Yongping Yue

    Molecular Microbiology and Immunology, University of Missouri, Columbia, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Dongsheng Duan

    Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Henk L Granzier

    Cellular and Molecular Medicine, University of Arizona, Tucson, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9516-407X
  18. Hazel H Szeto

    Social Profit Network, Menlo Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Wei-Jun Qian

    Biological Sciences Division, Pacific Northwest National Laboratory, Richland, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. David Marcinek

    Radiology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Michael J MacCoss

    Department of Genome Sciences, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Peter Rabinovitch

    Pathology, University of Washington, Seattle, United States
    For correspondence
    petersr@uw.edu
    Competing interests
    The authors declare that no competing interests exist.

Funding

Glenn Foundation for Medical Research (Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging)

  • Ying Ann Chiao

National Institute on Aging (5T32AG000057 Training Grant)

  • Ying Ann Chiao

National Institute on Aging (K99/R00 AG051735)

  • Ying Ann Chiao

National Institute on Aging (P01 AG001751)

  • Peter Rabinovitch

National Institute on Aging (P30 AG013280)

  • Peter Rabinovitch

Glenn Foundation for Medical Research (Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging)

  • Huiliang Zhang

American Heart Association (CDA 19CDA34660311)

  • Huiliang Zhang

National Heart, Lung, and Blood Institute (R35HL144998)

  • Henk L Granzier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mice were handled according to the guidelines of the Institutional Animal Care and Use Committee of the University of Washington and approved IACUC Protocol # 2174-23 . Mice were housed at 20ºC in an AAALAC accredited facility under Institutional Animal Care Committee supervision.

Copyright

© 2020, Chiao et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,215
    views
  • 626
    downloads
  • 83
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ying Ann Chiao
  2. Huiliang Zhang
  3. Mariya Sweetwyne
  4. Jeremy Whitson
  5. Ying Sonia Ting
  6. Nathan Basisty
  7. Lindsay K Pino
  8. Ellen Quarles
  9. Ngoc-Han Nguyen
  10. Matthew D Campbell
  11. Tong Zhang
  12. Matthew J Gaffrey
  13. Gennifer Merrihew
  14. Lu Wang
  15. Yongping Yue
  16. Dongsheng Duan
  17. Henk L Granzier
  18. Hazel H Szeto
  19. Wei-Jun Qian
  20. David Marcinek
  21. Michael J MacCoss
  22. Peter Rabinovitch
(2020)
Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice
eLife 9:e55513.
https://doi.org/10.7554/eLife.55513

Share this article

https://doi.org/10.7554/eLife.55513

Further reading

    1. Medicine
    2. Microbiology and Infectious Disease
    Kavidha Reddy, Guinevere Q Lee ... Thumbi Ndung'u
    Research Article

    Persisting HIV reservoir viruses in resting CD4 T cells and other cellular subsets are a barrier to cure efforts. Early antiretroviral therapy (ART) enables post-treatment viral control in some cases, but mechanisms remain unclear. We hypothesised that ART initiated before peak viremia impacts HIV-1 subtype C reservoirs. We studied 35 women at high risk of infection from Durban, South Africa, identified with hyperacute HIV by twice-weekly HIV-RNA testing. Participants included 11 starting ART at a median of 456 (297–1203) days post-onset of viremia (DPOV) and 24 at 1 (1–3) DPOV. Peripheral blood mononuclear cells (PBMCs) were used to measured total HIV-1 DNA by droplet digital PCR (ddPCR) and sequence viral reservoir genomes by full-length proviral sequencing (FLIP-seq). ART during hyperacute infection blunted peak viremia (p<0.0001), but contemporaneous total HIV-1 DNA did not differ (p=0.104). Over 1 year, a decline of total HIV-1 DNA was observed in early treated persons (p=0.0004), but not late treated. Among 697 viral genome sequences, the proviral genetic landscape differed between untreated, late treated, and early treated groups. Intact genomes after 1 year were higher in untreated (31%) versus late treated (14%) and early treated (0%). Treatment in both late and early infection caused more rapid decay of intact (13% and 51% per month) versus defective (2% and 35%) viral genomes. However, intact genomes persisted 1 year post chronic treatment but were undetectable with early ART. Early ART also reduced phylogenetic diversity of intact genomes and limited cytotoxic T lymphocyte immune escape variants in the reservoir. Overall, ART initiated in hyperacute HIV-1 subtype C infection did not impact reservoir seeding but was associated with rapid intact viral genome decay, reduced genetic complexity, and limited immune escape, which may accelerate reservoir clearance in combination with other interventional strategies.

    1. Cancer Biology
    2. Medicine
    Patrick Brandt, Dawayne Whittington ... Rebekah L Layton
    Research Article

    A doctoral-level internship program was developed at the University of North Carolina at Chapel Hill with the intent to create customizable experiential learning opportunities for biomedical trainees to support career exploration, preparation, and transition into their postgraduate professional roles. We report the outcomes of this program over a 5-year period. During that 5-year period, 123 internships took place at over 70 partner sites, representing at least 20 academic, for-profit, and non-profit career paths in the life sciences. A major goal of the program was to enhance trainees’ skill development and expertise in careers of interest. The benefits of the internship program for interns, host/employer, and supervisor/principal investigator were assessed using a mixed-methods approach, including surveys with closed- and open-ended responses as well as focus group interviews. Balancing stakeholder interests is key to creating a sustainable program with widespread support; hence, the level of support from internship hosts and faculty members were the key metrics analyzed throughout. We hypothesized that once a successful internship program was implemented, faculty culture might shift to be more accepting of internships; indeed, the data quantifying faculty attitudes support this. Furthermore, host motivation and performance expectations of interns were compared with results achieved, and this data revealed both expected and surprising benefits to hosts. Data suggests a myriad of benefits for each stakeholder group, and themes are cataloged and discussed. Program outcomes, evaluation data, policies, resources, and best practices developed through the implementation of this program are shared to provide resources that facilitate the creation of similar internship programs at other institutions. Program development was initially spurred by National Institutes of Health pilot funding, thereafter, successfully transitioning from a grant-supported model, to an institutionally supported funding model to achieve long-term programmatic sustainability.